73.80
+1.28
+(1.77%)
As of 9:48:28 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 8 | 7 |
| Avg. Estimate | 1.59B | 1.67B | 6.73B | 7.3B |
| Low Estimate | 1.59B | 1.65B | 6.68B | 7B |
| High Estimate | 1.6B | 1.69B | 6.79B | 7.46B |
| Year Ago Sales | 1.48B | 1.53B | 6.15B | 6.73B |
| Sales Growth (year/est) | 7.98% | 8.80% | 9.40% | 8.46% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| I5M.F | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.77% | 9.23% | 14.19% |
Upgrades & Downgrades
| Initiated | Truist Securities: Buy | 4/8/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/20/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 2/18/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/4/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/28/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 11/27/2024 |